As of Dec 14
| -0.37 / -3.22%|
The 9 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 15.00, with a high estimate of 28.00 and a low estimate of 9.00. The median estimate represents a +34.89% increase from the last price of 11.12.
The current consensus among 9 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.